JP2019089762A5 - - Google Patents

Download PDF

Info

Publication number
JP2019089762A5
JP2019089762A5 JP2018219226A JP2018219226A JP2019089762A5 JP 2019089762 A5 JP2019089762 A5 JP 2019089762A5 JP 2018219226 A JP2018219226 A JP 2018219226A JP 2018219226 A JP2018219226 A JP 2018219226A JP 2019089762 A5 JP2019089762 A5 JP 2019089762A5
Authority
JP
Japan
Prior art keywords
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018219226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019089762A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019089762A publication Critical patent/JP2019089762A/ja
Publication of JP2019089762A5 publication Critical patent/JP2019089762A5/ja
Pending legal-status Critical Current

Links

JP2018219226A 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法 Pending JP2019089762A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361779619P 2013-03-13 2013-03-13
US61/779,619 2013-03-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018044050A Division JP2018150298A (ja) 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法

Publications (2)

Publication Number Publication Date
JP2019089762A JP2019089762A (ja) 2019-06-13
JP2019089762A5 true JP2019089762A5 (enExample) 2019-10-10

Family

ID=50241450

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法
JP2018044050A Pending JP2018150298A (ja) 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Pending JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法
JP2018044050A Pending JP2018150298A (ja) 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Country Status (15)

Country Link
US (1) US9303043B2 (enExample)
EP (3) EP2970329A1 (enExample)
JP (6) JP6363120B2 (enExample)
KR (3) KR20180070715A (enExample)
CN (2) CN105377856B (enExample)
AR (1) AR095365A1 (enExample)
AU (3) AU2014230812B2 (enExample)
BR (1) BR112015020716A2 (enExample)
CA (6) CA2897618A1 (enExample)
IL (1) IL240793A0 (enExample)
MX (1) MX2015011438A (enExample)
NZ (1) NZ711192A (enExample)
RU (2) RU2018109979A (enExample)
SG (2) SG10201706760YA (enExample)
WO (1) WO2014140073A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9266903B2 (en) * 2013-12-16 2016-02-23 Genentech, Inc. Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazole-5-yl)-5,6-dihydrobenzo[F]imidazo [1,2-D][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
CN111909173B (zh) * 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
JP6522807B2 (ja) 2015-07-02 2019-05-29 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ベンゾオキサゼピンオキサゾリジノン化合物及び使用方法
CN105906635A (zh) * 2016-06-08 2016-08-31 上海大学 全氟烷基苯并氮杂*并喹喔啉衍生物及其合成方法
EP3492452B1 (en) * 2016-07-29 2022-08-31 Japan Tobacco Inc. Production method for pyrazole-amide compound
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
PL3851441T3 (pl) 2016-12-15 2023-11-06 F. Hoffmann-La Roche Ag Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu
CN108752237A (zh) * 2018-07-05 2018-11-06 四川青木制药有限公司 一种对氨基苯甲脒盐酸盐的新制备方法
BR112021011894A2 (pt) 2018-12-21 2021-09-08 Daiichi Sankyo Company, Limited Composição farmacêutica

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
ES2205944T3 (es) * 1998-10-23 2004-05-01 Dow Agrosciences Llc Compuestos de 3-(fenil sustituido)-5-(ciclopropil sustituido)-1,2,4-triazol.
HUP0400164A2 (hu) 2001-07-12 2004-07-28 Avecia Ltd. Mikrokapszulázott katalizátor, eljárás előállítására és alkalmazása
CA2463441A1 (en) * 2001-10-12 2003-05-08 Bayer Pharmaceuticals Corporation Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1945222B1 (en) 2005-11-02 2012-12-26 Bayer Pharma Aktiengesellschaft Pyrrolo[2,1-f] [1,2,4]-triazin-4-ylamines as igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
EA016527B1 (ru) * 2006-10-23 2012-05-30 ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК. Триазолопиридазиновые модуляторы протеинкиназ
BRPI0717320A2 (pt) * 2006-10-23 2013-10-22 Sgx Pharmaceuticals Inc Triazóis bicíclicos como moduladores de proteína cinase
CA2675755C (en) * 2007-01-19 2015-10-06 Xcovery, Inc. Pyridine and pyridazine derivatives as kinase inhibitors
WO2009055730A1 (en) * 2007-10-25 2009-04-30 Genentech, Inc. Process for making thienopyrimidine compounds
CN102015693B (zh) * 2008-02-21 2014-10-29 默沙东公司 作为erk抑制剂的化合物
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
US8263633B2 (en) 2009-09-28 2012-09-11 F. Hoffman-La Roche Ag Benzoxepin PI3K inhibitor compounds and methods of use
TWI423980B (zh) * 2009-09-28 2014-01-21 Hoffmann La Roche 苯并氧氮呯pi3k抑制劑化合物及使用方法
CA2778684A1 (en) * 2009-10-29 2011-05-05 Schering Corporation Bridged bicyclic piperidine derivatives and methods of use thereof
CN102558167A (zh) * 2010-12-29 2012-07-11 中国医学科学院药物研究所 Gk和ppar双重激动活性的噻唑烷二酮衍生物
KR20140032383A (ko) 2011-03-21 2014-03-14 에프. 호프만-라 로슈 아게 Pi3k p110 델타에 대하여 선택적인 벤즈옥사제핀 화합물 및 이의 사용 방법
NO3175985T3 (enExample) * 2011-07-01 2018-04-28
CN104379163A (zh) 2012-06-08 2015-02-25 霍夫曼-拉罗奇有限公司 用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合

Similar Documents

Publication Publication Date Title
JP2018150298A5 (enExample)
JP2018168171A5 (enExample)
JP2017008120A5 (enExample)
JP2020515557A5 (enExample)
JP2018030858A5 (enExample)
JP2018024670A5 (enExample)
JP2020040981A5 (enExample)
JP2017186358A5 (enExample)
JP2018521020A5 (enExample)
JP2017514877A5 (enExample)
JP2017137500A5 (enExample)
JP2019124943A5 (enExample)
JP2021503553A5 (enExample)
JP2013532130A5 (enExample)
JP2018186811A5 (enExample)
JP2011510079A5 (enExample)
JP2020183924A5 (enExample)
JP2018116258A5 (enExample)
JP2020043052A5 (enExample)
JP2018162319A5 (enExample)
JP2022507958A5 (enExample)
JP2021512134A5 (enExample)
JP2020049413A5 (enExample)
JP2019210167A5 (enExample)
JP2011037885A5 (enExample)